| Name | Title | Contact Details |
|---|
A global decentralized health platform that empowers patients with a self-sovereign health identity and aligns patients, providers, and payers to battle the global pandemic of chronic disease
Better Health Group is a national primary care platform that enables providers to shift focus to value-based care. They take a proactive approach by focusing on preventing disease rather than just treating symptoms.
Kolltan Pharmaceuticals is a private company founded in 2007 that is developing novel monoclonal antibody (mAb) drugs targeting receptor tyrosine kinases (RTKs). Kolltan's primary targets derive from seminal discoveries made in the laboratory of Dr. Joseph Schlessinger, Chairman of the Department of Pharmacology at the Yale School of Medicine, and in Kolltan’s laboratories. Dr. Schlessinger's laboratory has characterized a novel molecular mechanism underlying activation of RTKs providing, for the first time, a clear molecular explanation — at atomic resolution — for the oncogenic activity of mutations that have been identified in a variety of human cancers.
Mid-Atlantic Dental Partners delivers dental services through a partnership with dentists who are respected in their communities.
OPMEDIC Group Inc. is a Outremont, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.